Congenital toxoplasmosis
ORPHA:858DiseaseNot applicableAntenatal, Infancy, Neonatal
Фенотипы (HPO)26
Очень частый (80–99%)2
HP:0001622Premature birth
HP:0007703Abnormality of retinal pigmentation
Периодический (5–29%)24
HP:0000238Hydrocephalus
HP:0000252Microcephaly
HP:0000365Hearing impairment
HP:0000505Visual impairment
HP:0000568Microphthalmia
HP:0000639Nystagmus
HP:0000952Jaundice
HP:0001250Seizure
HP:0001252Hypotonia
HP:0001263Global developmental delay
HP:0001511Intrauterine growth retardation
HP:0001531Failure to thrive in infancy
HP:0001541Ascites
HP:0001640Cardiomegaly
HP:0001873Thrombocytopenia
HP:0001903Anemia
HP:0002014Diarrhea
HP:0002119Ventriculomegaly
HP:0002240Hepatomegaly
HP:0002514Cerebral calcification
HP:0002716Lymphadenopathy
HP:0002910Elevated circulating hepatic transaminase concentration
HP:0012733Macule
HP:0100543Cognitive impairment
Эпидемиология14
| Тип оценки | Класс распространённости | Среднее (на 100к) | Регион | Квалификация |
|---|---|---|---|---|
| Prevalence at birth | 1-5 / 10 000 | 33 | Europe | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 30 | France | Value and class |
| Prevalence at birth | 1-9 / 100 000 | 1 | Greece | Value and class |
| Prevalence at birth | 1-9 / 100 000 | 2.2 | United Kingdom | Value and class |
| Prevalence at birth | 1-9 / 100 000 | 7.3 | Sweden | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 30 | Denmark | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 50 | Switzerland | Value and class |
| Prevalence at birth | >1 / 1000 | 130 | Germany | Value and class |
| Prevalence at birth | >1 / 1000 | 113 | Poland | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 40 | Brazil | Value and class |
| Prevalence at birth | >1 / 1000 | 138 | Italy | Value and class |
| Prevalence at birth | 1-5 / 10 000 | 55 | United States | Value and class |
| Point prevalence | Unknown | — | Worldwide | Class only |
| Prevalence at birth | >1 / 1000 | 640 | Iran, Islamic Republic of | Value and class |
Лекарства и терапия
Источник: Open Targets Platform (в реальном времени)
Клинические исследования
Источник: ClinicalTrials.gov (в реальном времени)